DEA CANNABIS RESCHEDULING

PUBLIC COMMENT VIEWER

Here is a random public comment on the rescheduling of cannabis to Schedule III from Jean Robert.
This rescheduling is about medical marijuana only. It doesn’t legalize it for recreational use and is a step towards synchronizing and standardizing medical cannabis at the federal level. I support this as a father who’s daughter used medical marijuana to offset the effects of chemotherapy and immunotherapy during her cancer treatment from 2018 to 2020. It was also used to offset pain radiating from the tumor in her pelvis. Instead of using highly addictive OxyContin, she used a strain of medical marijuana designed for this in Massachusetts. It worked. To date, I believe 39 states have a medical marijuana program, and another 8 states have CBD with low THC. Extensive state level research was presented about the efficacy and safety of medical marijuana throughout the approval process at each state demonstrating its benefits. Their and the FDA analysis of medical marijuana provides a overwhelming body of evidence that it can help many people with a wide range of issues. But, like any prescription, there are some that should not receive it due to underlying circumstances. Rules, guidelines, and the medical establishment should take it from here, not politicians. The FDA, DEA and other federal agencies should work with their state counterparts to come up with a nationwide standarization that balances the needs of the individuals with the needs of providing safe guidelines for use. By moving it to schedule 3, research will be permitted to effectively deliver better and safer medical marijuana/THC/CBD to the marketplace where permitted. I do believe state sovereignty needs to be respected, but so should the individual needs of patients for a wide array ailments. I urge the Attorney General to approve rescheduling in an expedited manner.
Over 42,000 public comments were submitted. Public commenters, thank you for your courage!